Board of Directors

Brian M. Silver

As Freeline’s CFO and Head of Corporate Development, Brian Silver oversees the Company’s financial, corporate legal and business development operations, including corporate strategy, BD&L, legal and compliance, investor relations, accounting, financial planning and analysis, IT, tax and treasury. In just over two years at Freeline, Brian has raised over $300 million in capital, via a crossover financing as well as in one of the largest ever Nasdaq IPOs for a UK-based clinical-stage biotech company.

Before joining Freeline, Brian was Partner and Head of Biotechnology in the healthcare practice at Perella Weinberg Partners, a leading independent global advisory firm. Prior to that, Brian was a Managing Director in Morgan Stanley’s healthcare investment banking group and a corporate associate at Sullivan & Cromwell.

Brian has worked with a range of large and emerging pharmaceutical and biotechnology clients during his 25-year Wall Street career. His investment banking and corporate law advisory experience includes dozens of M&A and financing transactions across all capital markets, including IPOs, follow-ons, high yield and investment grade debt, and royalty financings. His M&A experience includes sell side and buy side transactions and leveraged buyouts, as well as reverse mergers and corporate restructurings.

Brian received a BA with honors from Harvard College and a JD with honors from the University of Chicago Law School.